Esr/ers white paper on lung cancer screening - Université de Lille Accéder directement au contenu
Article Dans Une Revue European Respiratory Journal Année : 2015

Esr/ers white paper on lung cancer screening


Lung cancer is the most frequently fatal cancer, with poor survival once the disease is advanced. Annual low dose computed tomography has shown a survival benefit in screening individuals at high risk for lung cancer. Based on the available evidence, the European Society of Radiology and the European Respiratory Society recommend lung cancer screening in comprehensive, quality-assured, longitudinal programmes within a clinical trial or in routine clinical practice at certified multidisciplinary medical centres. Minimum requirements include: standardised operating procedures for low dose image acquisition, computer-assisted nodule evaluation, and positive screening results and their management; inclusion/exclusion criteria; expectation management; and smoking cessation programmes. Further refinements are recommended to increase quality, outcome and cost-effectiveness of lung cancer screening: inclusion of risk models, reduction of effective radiation dose, computer-assisted volumetric measurements and assessment of comorbidities (chronic obstructive pulmonary disease and vascular calcification). All these requirements should be adjusted to the regional infrastructure and healthcare system, in order to exactly define eligibility using a risk model, nodule management and quality assurance plan. The establishment of a central registry, including biobank and image bank, and preferably on a European level, is strongly encouraged.
Fichier principal
Vignette du fichier
28.full.pdf (334.53 Ko) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-02525072 , version 1 (30-03-2020)




Hans-Ulrich Kauczor, Lorenzo Bonomo, Mina Gaga, Kristiaan Nackaerts, Nir Peled, et al.. Esr/ers white paper on lung cancer screening. European Respiratory Journal, 2015, 46, pp.28-39. ⟨10.1183/09031936.00033015⟩. ⟨hal-02525072⟩


19 Consultations
72 Téléchargements



Gmail Mastodon Facebook X LinkedIn More